Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at
Data from randomized trial will advance evidence for evaluation and treatment of heart disease by studying actual disease, atherosclerosisDENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the TRANSFORM trial at the American Hear...
Source: pharmiweb.com